"Medical Headline Jun" has just been established for a month (Viatris) is going to be laid off again...

(2020/12/18) Research and Development . . 2020 lung cancer field heavy research summary; in the second half of 2020 8 enterprises staged the annual "eat melon drama"; big open: only sell Class B OTC on the same day to close the certificate; MNC's PD-1 "Game of Thrones" climax has just begun ... (Click on the title to get the original text) "Medical 1st Time" just a month after the establishment of viatris to lay off workers? Is there you in this wave? Recently, it was reported in the media that Viatris Inc. is planning to lay off workers again... According to the information known, the planned layoffs come from the pain field.
said 20 per cent of anti-infection product line representatives in an area would be cut next week.
headlines: the cost of being abandoned by businesses.
"Pharmacy Manager" big liberalization: only sell Class B OTC on the same day to close the certificate December 18, Zhejiang Shaoxing City Market Bureau issued "on the franchise Class B over-the-counter drug retail enterprises operating approval to implement the notification commitment system notice."
The Notice will be in effect from 1 January 2021.
the headlines: send more texts, approval is greatly liberalized.
In the second half of 2020, eight large enterprises staged the annual "eat melon drama" in the first half of the year engaged in ventilators, masks, nucleic acid testing reagents and other medical device companies earned a pot full of money;
, there are so many enterprises recently frequently burst out of the "negative news", all kinds of tearing, helpless to stage, so that the people who eat melons live to see a few free "annual drama."
the headline bacteria: go to its dross to get its essence.
the climax of MNC's PD-1 "Game of Thrones" has just begun... The health-care negotiations are hilariously over, and PD-1 is the absolute protagonist.
In no way because it is the hottest target in the field of cancer immunotherapy, but also because around its MNC, biological upstate, old big drug companies, all the roles of the various appearances, all come out to see the skills, behind the scenes, you come to me.
their opponents hold PD-1, the health care negotiations are the test room is also a competition, win the game, rely on strength, but also need luck.
fact, the race started long before PD-1 was discovered.
Headlines: The global PD-1/PD-L1 drug market could reach $78.9 billion in 2030 .
: There are many new breakthroughs in lung cancer targeting and immunotherapy in 2020.
。